TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.

Howard M Stern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.